title: Nitric oxide synthesis by rat pleural mesothelial cells: induction by growth factors and lipopolysaccharide.
abstract: The purpose of this study was to determine if certain growth factors and bacterial products induce pleural mesothelial cells (PMC) to produce nitric oxide (NO). Confluent monolayers of rat PMC were exposed to epidermal growth factor (EGF), platelet-derived growth factor (PDGF), or lipopolysaccharide (LPS) individually and in various combinations for 24-72 h. Concentrations of nitrite and nitrate were quantified and used as an indirect measure of NO production. LPS stimulation resulted in a significant increase in nitrite/nitrate concentration, but neither EGF nor PDGF alone or combined had any significant effect relative to control. However, LPS combined with either EGF or PDGF caused a significant increase in nitrite/nitrate concentration relative to LPS alone and growth factor alone. The highest level level of nitrite/nitrate concentration was observed with the triple combination of LPS, EGF, and PDGF. Nitrite/nitrate accumulation was significantly increased at 24 h by all combinations, and continued to increase, with the highest concentration observed after 72 h of exposure. Nitrite/nitrate production was significantly inhibited by NG-nitro-L-arginine methyl ester and this inhibition was reversed by the addition of L-arginine, suggesting that nitrite and nitrate were derived from the L-arginine-dependent formation of NO. These data indicate that PMC can be induced to produce relatively large amounts of NO in response to growth factors combined with LPS.
authors.affiliation: Department of Medicine, Overton Brooks Veterans Affairs, Shreveport, Louisiana, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Owens
authors.forename: S A
authors.initials: SA
authors.lastname: Milligan
authors.forename: M B
authors.initials: MB
authors.lastname: Grisham
mesh_terms: D000293:Adolescent; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D004791:Enzyme Inhibitors / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D019331:NG-Nitroarginine Methyl Ester; D009566:Nitrates / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D009573:Nitrites / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D010994:Pleura / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D004791:Enzyme Inhibitors; D008070:Lipopolysaccharides; D009566:Nitrates; D009573:Nitrites; D010982:Platelet-Derived Growth Factor; D009569:Nitric Oxide; D004815:Epidermal Growth Factor; D001120:Arginine; D019331:NG-Nitroarginine Methyl Ester